The Immunohistochemistry Antibody Company

Home
Products
- All Antibodies
- IHC-plus Antibodies
Services
- Immunohistochemistry Studies
- Tissue Cross-Reactivity Screening
Distributors
Resources
- About our Tissue Bank
- Customer Support
- How to Buy
- IHC-plus Protocol
- LSBio Media
- Publications
- Antibody Reports
Company
- About LifeSpan
- Press Releases
- Holiday Schedule
- Contact Us

View Cart

Breast Cancer Screen 52 Tissue Microarray - LS-SBRCA52

This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.

Technical Help email

Request an IHC Study by email

PDF Spec Sheet - click here

Catalog ID:	LS-SBRCA52
Product Name:	Breast Cancer Screen 52
Description:	Breast infiltrating lobular carcinoma with adjacent normal/non-neoplastic breast
Format:	FFPE
Category:	Human Tumor and Adjacent Normal
QA/QC:	H&E reviewed; IHC validated with a positive control antibody
Storage:	Short term RT; Long term 4ºC
Clinical History:	No
Tissue Marker:	No
Stage/Grade:	No
Core Diameter:	1.5 mm
Core Thickness:	5 µm
Cases:	79
Cores:	80
Slides Per Set:	1

LS-SBRCA52 Tissue Microarray Map

Slide Number 1

LABEL

	1	2	3	4	5	6	7	8	9	10
A	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst
B	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst
C	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst
D	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst
E	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst
F	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst
G	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst
H	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst

Diagnosis Type Legend

Benign non-neoplastic

Diseased

Inflammatory

Malignant

Metastatic

Tumor

Unknown

Element Tissue Legend

Breast (Bst); Breast, Duct epithelium (Bst); Breast, Fatty tissue (Bst); Breast, Fibrous tissue and blood vessel (Bst);

LS-SBRCA52 Element Details

Slide	Position	Species	Gender	Age	Tissue	Diagnosis	Diagnosis Type
1	A1	Human	F	46 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	A2	Human	F	40 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	A3	Human	F	50 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	A4	Human	F	50 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	A5	Human	F	47 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	A6	Human	F	47 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	A7	Human	F	64 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	A8	Human	F	48 y	Breast, Duct epithelium (Bst)	Lobular carcinoma, infiltrating with hyperplasia	Malignant
1	A9	Human	F	46 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	A10	Human	F	45 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	B1	Human	F	59 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	B2	Human	F	48 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	B3	Human	F	41 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	B4	Human	F	74 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	B5	Human	F	44 y	Breast (Bst)	Carcinoma	Malignant
1	B6	Human	F	63 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	B7	Human	F	39 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	B8	Human	F	39 y	Breast (Bst)	Carcinoma	Malignant
1	B9	Human	F	55 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	B10	Human	F	58 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	C1	Human	F	50 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	C2	Human	F	47 y	Breast (Bst)	Lobular carcinoma in situ	Malignant
1	C3	Human	F	49 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	C4	Human	F	52 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	C5	Human	F	68 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	C6	Human	F	50 y	Breast, Duct epithelium (Bst)	Lobular carcinoma, infiltrating with hyperplasia	Malignant
1	C7	Human	F	41 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	C8	Human	F	49 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	C9	Human	F	58 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	C10	Human	F	35 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	D1	Human	F	53 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	D2	Human	F	53 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	D3	Human	F	37 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	D4	Human	F	39 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	D5	Human	F	42 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	D6	Human	F	72 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	D7	Human	F	39 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	D8	Human	F	64 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	D9	Human	F	52 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	D10	Human	F	58 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	E1	Human	F	49 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	E2	Human	F	63 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	E3	Human	F	52 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	E4	Human	F	40 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	E5	Human	F	39 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	E6	Human	F	43 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	E7	Human	F	56 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	E8	Human	F	38 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	E9	Human	F	58 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	E10	Human	F	44 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	F1	Human	F	52 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	F2	Human	F	71 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	F3	Human	F	46 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	F4	Human	F	53 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	F5	Human	F	49 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	F6	Human	F	39 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	F7	Human	F	49 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	F8	Human	F	47 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	F9	Human	F	70 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	F10	Human	F	67 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	G1	Human	F	42 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	G2	Human	F	47 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	G3	Human	F	45 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	G4	Human	F	48 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	G5	Human	F	55 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	G6	Human	F	46 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	G7	Human	F	49 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	G8	Human	F	53 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	G9	Human	F	33 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	G10	Human	F	40 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant
1	H1	Human	F	59 y	Breast (Bst)	Adjacent normal	Benign non-neoplastic
1	H2	Human	F	57 y	Breast (Bst)	Adjacent normal	Benign non-neoplastic
1	H3	Human	F	40 y	Breast, Fibrous tissue and blood vessel (Bst)	Adjacent normal with hyalinization	Diseased
1	H4	Human	F	32 y	Breast, Fatty tissue (Bst)	Adjacent normal	Benign non-neoplastic
1	H5	Human	F	20 y	Breast, Fibrous tissue and blood vessel (Bst)	Adjacent normal with hyalinization	Diseased
1	H6	Human	F	47 y	Breast (Bst)	Adjacent normal with degeneration	Diseased
1	H7	Human	F	48 y	Breast (Bst)	Adjacent normal	Benign non-neoplastic
1	H8	Human	F	72 y	Breast (Bst)	Adjacent normal	Benign non-neoplastic
1	H9	Human	F	31 y	Breast, Fibrous tissue and blood vessel (Bst)	Adjacent normal with hyalinization	Diseased
1	H10	Human	F	34 y	Breast (Bst)	Adjacent normal	Benign non-neoplastic

PLEASE NOTE

For RESEARCH USE ONLY. Not intended for human diagnostic or therapeutic purposes.

Not for resale without prior written consent from LifeSpan BioSciences, Inc.